Feedback / Questions
AFM24 - Affimed
https://www.globenewswire.com/news-release/2024/05/29/2889665/0/en/Affimed-Receives-Fast-Track-Designation-for-Combination-Therapy-of-AFM24-with-Atezolizumab-for-EGFR-Wild-Type-Non-Small-Cell-Lung-Cancer.html
May 29, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next